Alembic Pharmaceuticals reports 15% rise in Q1 consolidated net profit

05 Aug 2025 Evaluate

Alembic Pharmaceuticals has reported result for first quarter ended June 30, 2025 (Q1FY26). 

The company has reported 41.25% fall in its net profit at Rs 103.52 crore for the quarter ended June 30, 2025 as compared to Rs 176.19 crore for the same quarter in the previous year. However, the total income of the company increased by 1.57% at Rs 1501.96 crore for Q1FY26 as compared to Rs 1478.70 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 14.60% rise in its net profit at Rs 154.38 crore for Q1FY26 as compared to Rs 134.71 crore for the same quarter in the previous year. The total income of the company increased by 9.81% at Rs 1717.22 crore for Q1FY26 as compared to Rs 1563.83 crore for the corresponding quarter previous year.

Alembic Pharma Share Price

899.90 -2.30 (-0.25%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×